State Street SPDR S&P Biotech ETF (NYSE:XBI) has outperformed the market over the past 20 years by 3.16% on an annualized basis producing an average annual return of 12.55%. Currently, State Street SPDR S&P Biotech ETF has a market capitalization of $10.50 billion.
Buying $100 In XBI: If an investor had bought $100 of XBI stock 20 years ago, it would be worth $1,046.96 today based on a price of $155.23 for XBI at the time of writing.
State Street SPDR S&P Biotech ETF’s Performance Over Last 20 Years
Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment